Chemoinformaics analysis of (8S)-15-Acetyloxylabd-13-en-8-ol
| Molecular Weight | 350.543 | nRot | 5 |
| Heavy Atom Molecular Weight | 312.239 | nRig | 13 |
| Exact Molecular Weight | 350.282 | nRing | 2 |
| Solubility: LogS | -4.959 | nHRing | 0 |
| Solubility: LogP | 5.76 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 64.4841 |
| nHD | 1 | BPOL | 40.7259 |
| QED | 0.543 |
| Synth | 4.058 |
| Natural Product Likeliness | 2.911 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.934 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.614 |
| MDCK | 0.0000152 |
| BBB | 0.533 |
| PPB | 0.953195 |
| VDSS | 1.107 |
| FU | 0.0391112 |
| CYP1A2-inh | 0.063 |
| CYP1A2-sub | 0.15 |
| CYP2c19-inh | 0.151 |
| CYP2c19-sub | 0.894 |
| CYP2c9-inh | 0.263 |
| CYP2c9-sub | 0.57 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.253 |
| CYP3a4-inh | 0.258 |
| CYP3a4-sub | 0.229 |
| CL | 8.434 |
| T12 | 0.1 |
| hERG | 0.01 |
| Ames | 0.007 |
| ROA | 0.016 |
| SkinSen | 0.395 |
| Carcinogencity | 0.073 |
| EI | 0.351 |
| Respiratory | 0.837 |
| NR-Aromatase | 0.097 |
| Antiviral | Yes |
| Prediction | 0.630481 |